BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 25531324)

  • 1. STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer.
    Zhang Z; Liu X; Feng B; Liu N; Wu Q; Han Y; Nie Y; Wu K; Shi Y; Fan D
    Oncogene; 2015 Sep; 34(37):4808-20. PubMed ID: 25531324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STIM1 overexpression promotes colorectal cancer progression, cell motility and COX-2 expression.
    Wang JY; Sun J; Huang MY; Wang YS; Hou MF; Sun Y; He H; Krishna N; Chiu SJ; Lin S; Yang S; Chang WC
    Oncogene; 2015 Aug; 34(33):4358-67. PubMed ID: 25381814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
    Tao Y; Han T; Zhang T; Ma C; Sun C
    Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer.
    Ma W; Liu B; Li J; Jiang J; Zhou R; Huang L; Li X; He X; Zhou Q
    Biomed Pharmacother; 2018 Sep; 105():670-676. PubMed ID: 29906744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRT1 promotes epithelial-mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression.
    Cheng F; Su L; Yao C; Liu L; Shen J; Liu C; Chen X; Luo Y; Jiang L; Shan J; Chen J; Zhu W; Shao J; Qian C
    Cancer Lett; 2016 Jun; 375(2):274-283. PubMed ID: 26975631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
    Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
    J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of clinical features and genetic profiles of stromal interaction molecule 1 (STIM1) in colorectal cancers.
    Wong HS; Chang WC
    Oncotarget; 2015 Dec; 6(39):42169-82. PubMed ID: 26543234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
    Wu Y; Peng Y; Wu M; Zhang W; Zhang M; Xie R; Zhang P; Bai Y; Zhao J; Li A; Nan Q; Chen Y; Ren Y; Liu S; Wang J
    Oncotarget; 2016 Aug; 7(32):51150-51162. PubMed ID: 27223064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer.
    Li Y; Lv Z; He G; Wang J; Zhang X; Lu G; Ren X; Wang F; Zhu X; Ding Y; Liao W; Ding Y; Liang L
    Oncotarget; 2015 Apr; 6(11):9099-112. PubMed ID: 25868860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT.
    Chen J; Zhang H; Chen Y; Qiao G; Jiang W; Ni P; Liu X; Ma L
    Exp Cell Res; 2017 Mar; 352(1):104-112. PubMed ID: 28161537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition.
    Zhao S; Sun H; Jiang W; Mi Y; Zhang D; Wen Y; Cheng D; Tang H; Wu S; Yu Y; Liu X; Cui W; Zhang M; Sun X; Zhou Z; Peng Z; Yan D
    Mol Cancer; 2017 Jan; 16(1):12. PubMed ID: 28095858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Orai1 and STIM1 expressions upregulate MACC1 expression to promote tumor cell proliferation, metabolism, migration, and invasion in human gastric cancer.
    Xia J; Wang H; Huang H; Sun L; Dong S; Huang N; Shi M; Bin J; Liao Y; Liao W
    Cancer Lett; 2016 Oct; 381(1):31-40. PubMed ID: 27431311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of vinculin and membrane-bound β-catenin promotes metastasis and predicts poor prognosis in colorectal cancer.
    Li T; Guo H; Song Y; Zhao X; Shi Y; Lu Y; Hu S; Nie Y; Fan D; Wu K
    Mol Cancer; 2014 Dec; 13():263. PubMed ID: 25496021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis.
    Rokavec M; Bouznad N; Hermeking H
    Cell Mol Gastroenterol Hepatol; 2019; 7(4):783-802. PubMed ID: 30831320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLLT10 promotes tumor migration, invasion, and metastasis in human colorectal cancer.
    Jing X; Wu H; Cheng X; Chen X; Zhang Y; Shi M; Zhang T; Wang X; Zhao R
    Scand J Gastroenterol; 2018 Aug; 53(8):964-971. PubMed ID: 30102091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-187, a downstream effector of TGFβ pathway, suppresses Smad-mediated epithelial-mesenchymal transition in colorectal cancer.
    Zhang F; Luo Y; Shao Z; Xu L; Liu X; Niu Y; Shi J; Sun X; Liu Y; Ding Y; Zhao L
    Cancer Lett; 2016 Apr; 373(2):203-13. PubMed ID: 26820227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orai1, a Direct Target of microRNA-519, Promotes Progression of Colorectal Cancer via Akt/GSK3β Signaling Pathway.
    Deng W; Wang J; Zhang J; Cai J; Bai Z; Zhang Z
    Dig Dis Sci; 2016 Jun; 61(6):1553-60. PubMed ID: 26792278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4.
    He Z; Yu L; Luo S; Li M; Li J; Li Q; Sun Y; Wang C
    BMC Cancer; 2017 Feb; 17(1):140. PubMed ID: 28209128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.
    Liu YP; Zhu HF; Liu DL; Hu ZY; Li SN; Kan HP; Wang XY; Li ZG
    Oncotarget; 2016 Nov; 7(47):77306-77318. PubMed ID: 27764793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.